Europe's Premier Hub for Strategic Biopharma Partnerships: Driving Innovation and Excellence in Outsourced Manufacturing.
Contract Manufacturing Europe 2025 distinguishes itself as one of the most focused and strategic events in the biopharmaceutical sector across Europe. Unlike broader pharmaceutical conferences, this event zeroes in on the niche yet critical area of biopharma contract manufacturing, where the complexity and regulatory demands of biologics production require highly specialized solutions.
Given the market's projected growth to nearly $30 billion by 2028, driven by the rising demand for biologics and biosimilars, the event offers unparalleled opportunities for companies to explore the latest innovations and form strategic partnerships. With major industry players like Boehringer Ingelheim and Lonza making significant investments in Europe, this conference provides a unique platform for CMOs and biopharma companies to address the sector's most pressing challenges and opportunities in an intimate, highly networked setting.
In a landscape where the development and manufacturing of biologics are becoming increasingly complex and essential, Contract Manufacturing Europe 2025 stands out as the go-to event for companies aiming to streamline their operations, ensure regulatory compliance, and accelerate time-to-market for new therapies. This targeted focus and the emphasis on high-level networking set it apart from other conferences, making it an essential gathering for leaders in the biopharma contract manufacturing space.
Insights into the Biopharma Contract Manufacturing Market
Limited Super
GBP 850Â
*END-USER PRICING IS APPLICABLE to :
Company Profiles:Â Local Biopharma and BIG Pharma, Europe Academic & Research Institutes
Job Profiles: Manufacturing, Bioprocessing, Production, USP, DSP, Operations, Site Heads, Drug Substance and Product Manufacturing, Process Development, Quality, Analytics and other related technical designations.
Â
Limited Super
GBP 2,050
*SOLUTION PROVIDER PRICING IS APPLICABLE to
Company Profile: Service & Solution Providers, Europe/UK and International biopharma, CMO's /CDMO's and Europe Academic & Research Institutes
Job Profiles: Business Development, Marketing & Sales
Â
Limited Super
GBP 850Â
*END-USER PRICING IS APPLICABLE to :
Company Profiles:Â Local Biopharma and BIG Pharma, Europe Academic & Research Institutes
Job Profiles: Manufacturing, Bioprocessing, Production, USP, DSP, Operations, Site Heads, Drug Substance and Product Manufacturing, Process Development, Quality, Analytics and other related technical designations.
Â
Limited Super
GBP 2,050
*SOLUTION PROVIDER PRICING IS APPLICABLE to
Company Profile: Service & Solution Providers, Europe/UK and International biopharma, CMO's /CDMO's and Europe Academic & Research Institutes
Job Profiles: Business Development, Marketing & Sales
Â
IMAPAC is the go-to holistic producer of live events, biopharma data and digital marketing solutions for the global biopharmaceutical industry.
© 2024 Imapac. All rights reserved. Trade marks are owned by or licensed to imapac.
IMAPAC requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and to learn more about our privacy practices and our commitment to protecting your privacy, please review our Privacy Policy.
IMAPAC requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and to learn more about our privacy practices and our commitment to protecting your privacy, please review our Privacy Policy.